Glen Firestone

Glen Firestone has a distinguished 25-year career as an executive leader spanning biotech, pharmaceutical, and technology companies. He has utilized his deep commercial and strategic expertise to build businesses, launch breakthrough therapies, improve patients’ lives, and create value.

Prior to joining Attralus, Glen led a consulting business advising biotech companies on corporate strategy, commercialization, marketing, product development, market access, portfolio prioritization, business development, and valuations. Glen also served as a strategic advisor to Valo Health, a technology company using machine intelligence to accelerate the discovery and development of novel treatments. Prior to Valo, he was VP, Head of Commercialization at Tmunity Therapeutics, a private clinical-stage biotech company developing novel CAR-T cell therapies. In addition, Glen spent 20 years as a commercial executive at Merck with responsibility for leading many Global and U.S. franchises, including the cardiovascular business, delivered growth strategies building multibillion dollar product portfolios, successfully launching 12 innovative therapies, negotiating business development deals, and building partnerships.

Glen earned an M.B.A from Harvard Business School and a B.S in Mechanical Engineering from Rutgers University.